Source: Philstar Author: Sheila Crisostomo

MANILA, Philippines — Another private hospital was given a compassionate special permit (CSP) to use Ivermectin as treatment for COVID-19 patients, the Food and Drug Administration (FDA) said yesterday.

According to FDA director general Eric Domingo, there are now two private hospitals, which he refused to identify, that can use the mainly veterinary drug to treat their COVID-19 patients.

“As of (Thursday), there was a second hospital applicant for CSP. (Yesterday) morning, it was approved already,” he noted.

The CSP is valid for one year and can only be used by doctors of these hospitals.

Under the protocols, hospitals granted a CSP can use Ivermectin on an indicated number of patients. Once they consume the number of patients in their application, they can apply for CSP again.







Related: More Vaccine Blood Clots – Craig Kelly Backed Up By Medical Specialists Supporting Ivermectin!

American Hero: Ralph C. Lorigo Fights for Client Rights Including Access to Ivermectin for COVID-19 Patients At Risk

Dr. Peter McCullough blames high COVID death toll on massive censorship of effective early treatment protocols such as hydroxychloroquine & ivermectin

SUCCESS: SETTLEMENT REGARDING IVERMECTIN NOW AN ORDER OF COURT – South Africa

Argentina Ministry of Health Clinical Trial: Ivermectin Shows Benefit Treating Outpatients with Mild COVID-19

Top Yale Doctor/Researcher: ‘Ivermectin works,’ including for long-haul COVID

Share on facebook
Share on twitter
Share on whatsapp
On Trend

Latest Stories

Stark madness to ban ivermectin

Buried in the note is the real reason for making ivermectin inaccessible – the fear that persons taking it ‘may elect not to be vaccinated as part of the national Covid-19 vaccination program’. This is outrageous. When someone is infected with Covid, it is too late to bother with vaccination. They need early treatment. To deny it to coerce them into accepting a vaccine, one of whose side-effects is death, is immoral.

Read More »

Australia’s TGA Bans GPs from Prescribing Ivermectin

Australia’s medicine and therapeutic regulatory, the Therapeutic Good Administration (TGA) recently took the gloves off with Ivermectin, the economical anti-parasitic drug associated with at least 63 completed clinical trials involving SARS-CoV-2, the virus behind COVID-19. Now TGA formally places a national prohibition on off-label prescribing of ivermectin to all general practitioners. A comparable move as to what TGA did with hydroxychloroquine in 2020. Clearly further evidence of tightening encroachment of the critically important doctor-patient treatment relationship allowing consent to medical treatment using off-label medications. Of course, this isn’t occurring in a vacuum—it’s part of an unfolding, integrated and what have the signs of a coordinated and orchestrated government action to stop any and all treatments other than those the government declares acceptable.

Read More »